, Boubacar Malaria Plasmodium falciparum Resistance to IgG 4 Levels Are Associated with Human High Immunoglobulin G 2 ( IgG 2 ) and Low

[1]  L. Abel,et al.  Analyse des facteurs génétiques contrôlant l’infection palustre chez l’homme , 1999 .

[2]  L. Abel,et al.  Malaria in humans: Plasmodium falciparum blood infection levels are linked to chromosome 5q31-q33. , 1998, American journal of human genetics.

[3]  B. Greenwood,et al.  IgG3 antibodies to Plasmodium falciparum merozoite surface protein 2 (MSP2): increasing prevalence with age and association with clinical immunity to malaria. , 1998, The American journal of tropical medicine and hygiene.

[4]  S. Surrey,et al.  A naturally occurring mutation in Fc gamma RIIA: a Q to K127 change confers unique IgG binding properties to the R131 allelic form of the receptor. , 1998, Blood.

[5]  M. Cornet,et al.  Isotypic analysis of maternally transmitted Plasmodium falciparum‐specific antibodies in Cameroon, and relationship with risk of P. falciparum infection , 1997, Clinical and experimental immunology.

[6]  W. Hawley,et al.  Natural immune response to the C-terminal 19-kilodalton domain of Plasmodium falciparum merozoite surface protein 1 , 1996, Infection and immunity.

[7]  P. Deloron,et al.  IgG1 and IgG2 antibody responses to Plasmodium falciparum exoantigens correlate inversely and positively, respectively, to the number of malaria attacks. , 1996, FEMS immunology and medical microbiology.

[8]  C. Rogier,et al.  Pattern of immunoglobulin isotype response to Plasmodium falciparum blood-stage antigens in individuals living in a holoendemic area of Senegal (Dielmo, west Africa). , 1996, The American journal of tropical medicine and hygiene.

[9]  E. Riley,et al.  Human antibody response to Plasmodium falciparum merozoite surface protein 2 is serogroup specific and predominantly of the immunoglobulin G3 subclass , 1995, Infection and immunity.

[10]  H. Bouharoun-Tayoun,et al.  Mechanisms underlying the monocyte-mediated antibody-dependent killing of Plasmodium falciparum asexual blood stages , 1995, The Journal of experimental medicine.

[11]  J. Baird.  Host age as a determinant of naturally acquired immunity to Plasmodium falciparum. , 1995, Parasitology today.

[12]  J. M. Osborne,et al.  Ethnic variation in frequency of an allelic polymorphism of human Fc gamma RIIA determined with allele specific oligonucleotide probes. , 1994, Journal of immunological methods.

[13]  Sunetra Gupta,et al.  A theoretical framework for the immunoepidemiology of Plasmodium falciparum malaria , 1994, Parasite immunology.

[14]  R. Montelaro,et al.  A versatile synthetic peptide-based ELISA for identifying antibody epitopes. , 1994, Journal of immunological methods.

[15]  A. Holder,et al.  Immunization against malaria with a recombinant protein , 1994, Parasite immunology.

[16]  C. Chougnet,et al.  Isotypic analysis of Plasmodium falciparum-specific antibodies and their relation to protection in Madagascar , 1993, Infection and immunity.

[17]  C. Long,et al.  Immunity to blood stages of malaria. , 1993, Current opinion in immunology.

[18]  J. Cooper.  Merozoite surface antigen-I of plasmodium. , 1993, Parasitology today.

[19]  P. Parren,et al.  On the interaction of IgG subclasses with the low affinity Fc gamma RIIa (CD32) on human monocytes, neutrophils, and platelets. Analysis of a functional polymorphism to human IgG2. , 1992, The Journal of clinical investigation.

[20]  A. Holder,et al.  Naturally acquired cellular and humoral immune responses to the major merozoite surface antigen (Pf MSP1) of Plasmodium falciparum are associated with reduced malaria morbidity , 1992, Parasite immunology.

[21]  P. Druilhe,et al.  Plasmodium falciparum malaria: evidence for an isotype imbalance which may be responsible for delayed acquisition of protective immunity , 1992, Infection and immunity.

[22]  A. Saul,et al.  Protective immunization with invariant peptides of the Plasmodium falciparum antigen MSA2. , 1992, Journal of immunology.

[23]  D. Metcalf.  Control of granulocytes and macrophages: molecular, cellular, and clinical aspects. , 1991, Science.

[24]  A. Saul,et al.  Immunological fine structure of the variable and constant regions of a polymorphic malarial surface antigen from Plasmodium falciparum. , 1991, Molecular and biochemical parasitology.

[25]  B. Greenwood,et al.  Association between immune recognition of the malaria vaccine candidate antigen Pf155/RESA and resistance to clinical disease: a prospective study in a malaria-endemic region of west Africa. , 1991, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[26]  K. Marsh,et al.  Naturally acquired immunity to Plasmodium falciparum. , 1991, Immunology today.

[27]  A. Sabchareon,et al.  Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes , 1990, The Journal of experimental medicine.

[28]  P. Perlmann,et al.  Dissection of the human antibody response to the malaria antigen Pf155/RESA into epitope specific components , 1989, Immunological reviews.

[29]  A. Capron,et al.  Functional role of human IgG subclasses in eosinophil-mediated killing of schistosomula of Schistosoma mansoni. , 1989, Journal of immunology.

[30]  P. Romero,et al.  Induction of protective immunity against experimental infection with malaria using synthetic peptides , 1987, Nature.

[31]  R. Coppel,et al.  Immunization of Aotus monkeys with recombinant proteins of an erythrocyte surface antigen of Plasmodium falciparum , 1986, Nature.

[32]  K. Marsh,et al.  Antigens induced on erythrocytes by P. falciparum: expression of diverse and conserved determinants. , 1986, Science.

[33]  J. Dedet,et al.  In vitro and in vivo studies on protective and inhibitory antibodies against Plasmodium falciparum in the Saimiri monkey. , 1984, Journal of immunology.

[34]  C. Lambros,et al.  Synchronization of Plasmodium falciparum erythrocytic stages in culture. , 1979, The Journal of parasitology.

[35]  I. McGregor,et al.  Gamma-Globulin and Acquired Immunity to Human Malaria , 1961, Nature.

[36]  J. Banchereau,et al.  Interleukin-4 and interleukin-13: their similarities and discrepancies. , 1998, International reviews of immunology.

[37]  L. Abel,et al.  Human malaria: Segregation analysis of blood infection levels in a suburban area and a rural area in Burkina Faso , 1998, Genetic epidemiology.

[38]  M. Poncz,et al.  Rapid detection of the Fc gamma RIIA-H/R 131 ligand-binding polymorphism using an allele-specific restriction enzyme digestion (ASRED). , 1996, Journal of immunological methods.

[39]  H. Groux,et al.  Opsonization as an effector mechanism in human protection against asexual blood stages of Plasmodium falciparum: functional role of IgG subclasses. , 1990, Research in immunology.